1. Home
  2. NWFL vs RZLT Comparison

NWFL vs RZLT Comparison

Compare NWFL & RZLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Norwood Financial Corp.

NWFL

Norwood Financial Corp.

HOLD

Current Price

$34.63

Market Cap

366.2M

Sector

Finance

ML Signal

HOLD

Logo Rezolute Inc. (NV)

RZLT

Rezolute Inc. (NV)

HOLD

Current Price

$3.81

Market Cap

420.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NWFL
RZLT
Founded
1870
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
366.2M
420.8M
IPO Year
1996
2011

Fundamental Metrics

Financial Performance
Metric
NWFL
RZLT
Price
$34.63
$3.81
Analyst Decision
Hold
Strong Buy
Analyst Count
1
6
Target Price
$33.00
$9.67
AVG Volume (30 Days)
22.6K
1.2M
Earning Date
04-27-2026
05-13-2026
Dividend Yield
4.39%
N/A
EPS Growth
15150.00
26.32
EPS
1.21
N/A
Revenue
$7,999,000.00
N/A
Revenue This Year
$34.35
N/A
Revenue Next Year
$5.55
N/A
P/E Ratio
$28.64
N/A
Revenue Growth
8.11
N/A
52 Week Low
$23.82
$1.07
52 Week High
$35.48
$11.46

Technical Indicators

Market Signals
Indicator
NWFL
RZLT
Relative Strength Index (RSI) 55.86 28.98
Support Level $33.26 $3.71
Resistance Level $35.28 $3.98
Average True Range (ATR) 0.69 0.25
MACD -0.02 -0.07
Stochastic Oscillator 58.03 9.57

Price Performance

Historical Comparison
NWFL
RZLT

About NWFL Norwood Financial Corp.

Norwood Financial Corp is a U.S.-based bank holding company. It offers various personal and business credit services, trust and investment products, and real estate settlement services to consumers, businesses, nonprofit organizations, and municipalities in each of the communities that the bank serves. The bank also manages automated teller machines at its branch location. It serves the Pennsylvanian counties of Wayne, Pike, Monroe, and Lackawanna, as well as Susquehanna County.

About RZLT Rezolute Inc. (NV)

Rezolute Inc is a clinical-stage biopharmaceutical company focused on developing therapies for rare and metabolic diseases. The company aims to address unmet medical needs in conditions like congenital hyperinsulinism, a rare endocrine disorder causing excessive insulin production and resulting hypoglycemia. Rezolute's pipeline includes drug candidates designed to improve patient outcomes while reducing treatment burdens. The company engages in research, development, and clinical trials to advance its therapies and collaborates with medical communities and patient groups to support its objectives. Revenue and value creation depend largely on successful product development and regulatory approvals.

Share on Social Networks: